Jaipur
08042782001
+918824471531

Budesonide, Voglibose and Metformin Hydrochloride for Asthma and Diabetes Management

BUDESHINE 200 INH is a carefully formulated combination medicine containing Budesonide Inhalation I.P., Voglibose I.P. 0.2 mg, and Metformin Hydrochloride I.P. 500 mg. Designed for individuals managing respiratory and metabolic disorders, this medication combines the anti-inflammatory benefits of budesonide with the blood sugar-lowering effects of voglibose and metformin. Developed by Steris Healthcare Pvt. Ltd., BUDESHINE 200 INH is trusted for its efficacy, safety, and quality.

Budesonide, a corticosteroid, targets inflammation in the airways, helping patients with asthma or chronic obstructive pulmonary disease (COPD). Meanwhile, voglibose and metformin work synergistically to regulate blood glucose levels, making this combination suitable for patients managing type 2 diabetes alongside respiratory conditions.

Uses

BUDESHINE 200 INH is primarily used for:

  • Asthma and COPD Management: Budesonide inhalation helps reduce inflammation, improve breathing, and control chronic respiratory symptoms.

  • Type 2 Diabetes: The combination of voglibose (an alpha-glucosidase inhibitor) and metformin (a biguanide) helps regulate postprandial and fasting blood sugar levels.

  • Dual Management: Ideal for patients with coexisting respiratory issues and diabetes, offering a comprehensive approach to health.
    Benefits

Using BUDESHINE 200 INH offers multiple health benefits:

  1. Effective Airway Control: Budesonide reduces airway inflammation, preventing asthma attacks and improving overall lung function.

  2. Improved Blood Sugar Control: Voglibose slows carbohydrate absorption, while metformin reduces hepatic glucose production, together maintaining steady glucose levels.

  3. Convenience: The combination therapy reduces the need for multiple medications, simplifying daily treatment routines.

  4. Better Quality of Life: By controlling both respiratory and metabolic conditions, patients experience fewer complications and enhanced wellbeing.

Dosage

The dosage of BUDESHINE 200 INH should always be guided by a healthcare professional based on the patient’s condition:

  • Budesonide Inhalation: Typically used twice daily, with dosage adjusted according to asthma or COPD severity.

  • Voglibose 0.2 mg: Usually taken before meals to control postprandial blood sugar spikes.

  • Metformin Hydrochloride 500 mg: Often administered once or twice daily with meals to minimize gastrointestinal side effects.

Important: Never adjust the dosage on your own. Consistent use, along with regular monitoring of blood sugar and lung function, ensures optimal results.

Side Effects

Like all medications, BUDESHINE 200 INH may cause side effects, although not everyone experiences them. Common side effects include:

  • Budesonide: Oral thrush, cough, hoarseness, or mild throat irritation.

  • Voglibose: Bloating, gas, diarrhea, or abdominal discomfort.

  • Metformin: Nausea, mild stomach upset, or metallic taste in the mouth.

Serious side effects are rare but may include severe allergic reactions, persistent shortness of breath, or significant gastrointestinal discomfort. Immediate medical attention is advised if such symptoms occur.

Precautions and Warning

Before using BUDESHINE 200 INH, patients should be aware of certain precautions:

  • Allergies: Avoid if allergic to budesonide, voglibose, metformin, or other corticosteroids.

  • Medical Conditions: Inform your doctor about kidney or liver disorders, heart disease, or gastrointestinal problems.

  • Pregnancy and Lactation: Consult a physician before use.

  • Regular Monitoring: Blood glucose levels, kidney function, and respiratory health should be regularly checked during treatment.

  • Inhalation Technique: Proper inhaler technique is crucial to ensure maximum efficacy of budesonide.
    Conclusion

BUDESHINE 200 INH, with its unique combination of Budesonide Inhalation I.P., Voglibose I.P., and Metformin Hydrochloride I.P., offers a holistic solution for patients managing respiratory issues alongside type 2 diabetes. Its dual-action approach not only helps control airway inflammation but also stabilizes blood sugar levels, improving overall health and quality of life.

Trusted for its safety, efficacy, and convenience, BUDESHINE 200 INH stands out as an essential therapy for patients seeking reliable management of both respiratory and metabolic conditions. Always follow your healthcare provider’s guidance for dosage and monitoring to maximize benefits and minimize risks.


 2025-11-21T05:51:53

Keywords